(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil...
Stats | |
---|---|
आज की मात्रा | 5 317.00 |
औसत मात्रा | 2 653.00 |
बाजार मूल्य | 16.88M |
EPS | $0 ( 2024-03-15 ) |
अगली कमाई की तारीख | ( $0.0300 ) 2024-06-12 |
Last Dividend | $0.0750 ( 2023-03-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 24.50 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-10 | Perlysky Dov | Buy | 20 000 | Stock Option |
2024-01-10 | Wiesen Irving L | Buy | 20 000 | Stock Option |
2024-01-10 | Michel Kirk Wheeler | Buy | 20 000 | Stock Option |
2024-01-10 | Spindel Howard | Buy | 20 000 | Stock Option |
2024-01-05 | Michel Kirk Wheeler | Buy | 20 000 | Common Stock |
INSIDER POWER |
---|
-0.59 |
Last 100 transactions |
Buy: 983 844 | Sell: 1 082 895 |
Pharma-Bio Serv, Inc. सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Pharma-Bio Serv, Inc. वित्तीय
Annual | 2023 |
राजस्व: | $16.98M |
सकल लाभ: | $5.07M (29.84 %) |
EPS: | $0.0570 |
FY | 2023 |
राजस्व: | $16.98M |
सकल लाभ: | $5.07M (29.84 %) |
EPS: | $0.0570 |
FY | 2022 |
राजस्व: | $19.40M |
सकल लाभ: | $4.88M (25.16 %) |
EPS: | $0.0438 |
FY | 2021 |
राजस्व: | $20.12M |
सकल लाभ: | $5.36M (26.65 %) |
EPS: | $-0.0910 |
Financial Reports:
No articles found.
Pharma-Bio Serv, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0.0750 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0750 | 2018-10-12 |
Last Dividend | $0.0750 | 2023-03-28 |
Next Dividend | $0 | N/A |
Payout Date | 2023-04-14 | |
Next Payout Date | N/A | |
# dividends | 6 | -- |
Total Paid Out | $0.450 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.94 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.95 | |
Div. Directional Score | 7.93 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
CNLHN | Ex Dividend Knight | 2023-08-09 | Quarterly | 0 | 0.00% | |
UEPEP | Ex Dividend Knight | 2023-07-20 | Quarterly | 0 | 0.00% | |
RSRV | Ex Dividend Junior | 2023-06-06 | Annually | 0 | 0.00% | |
PFBX | Ex Dividend Knight | 2023-05-01 | Annually | 0 | 0.00% | |
FREVS | Ex Dividend Knight | 2023-08-31 | Quarterly | 0 | 0.00% | |
EFSI | Ex Dividend Knight | 2023-08-04 | Quarterly | 0 | 0.00% | |
BVHBB | Ex Dividend Junior | 2023-09-01 | Semi-Annually | 0 | 0.00% | |
TBTC | Ex Dividend Junior | 2023-08-31 | Sporadic | 0 | 0.00% | |
QNBC | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
JUVF | Ex Dividend Knight | 2023-08-16 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0405 | 1.500 | 9.19 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0319 | 1.200 | 8.94 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0395 | 1.500 | -0.673 | -1.009 | [0.1 - 1] |
payoutRatioTTM | 2.81 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 5.10 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.97 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.744 | 1.500 | 1.425 | 2.14 | [0.2 - 2] |
debtRatioTTM | 0.0161 | -1.500 | 9.73 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 1.422 | 1.000 | -0.585 | -0.585 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0758 | 2.00 | 9.97 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0758 | 2.00 | 9.96 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0219 | -1.500 | 9.91 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.289 | 1.000 | 8.52 | 8.52 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0232 | 1.000 | -1.536 | -1.536 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 5.62 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.786 | 0.800 | 8.09 | 6.47 | [0.5 - 2] |
Total Score | 10.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 27.53 | 1.000 | 7.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0395 | 2.50 | -0.432 | -1.009 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0758 | 2.00 | 9.97 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 10.20 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0758 | 2.00 | 9.97 | 10.00 | [0 - 30] |
payoutRatioTTM | 2.81 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -0.137 | 1.500 | -4.24 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.115 | 1.000 | 9.62 | 0 | [0.1 - 0.5] |
Total Score | 4.95 |
Pharma-Bio Serv, Inc.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं